In general I agree, genetic and even epigenetic testing tends to identify problems at a point where gene therapy is no longer an option, so why bother? But if y

In general I agree, genetic and even epigenetic testing tends to identify problems at a point where gene therapy is no longer an option, so why bother? But if you can take tissue samples, we're getting to the point were we can detect cancers from SVs and fusions fairly easily. It'd be a easy sale to sell blood tests for leukemia, for example. That alone won't justify the cost, but we're making progress.